Compare THRY & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | THRY | QSI |
|---|---|---|
| Founded | 2012 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 179.6M | 165.6M |
| IPO Year | 2020 | 2020 |
| Metric | THRY | QSI |
|---|---|---|
| Price | $1.20 | $1.38 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $4.00 | $2.30 |
| AVG Volume (30 Days) | 505.1K | ★ 9.3M |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 100.50 | 28.17 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $785,015,000.00 | $2,436,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $406.32 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.11 | $0.69 |
| 52 Week High | $12.57 | $2.42 |
| Indicator | THRY | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 28.02 | 60.23 |
| Support Level | N/A | $0.81 |
| Resistance Level | $2.17 | $1.66 |
| Average True Range (ATR) | 0.09 | 0.17 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 20.25 | 59.23 |
Thryv Holdings Inc is dedicated to supporting local, independent service-based businesses and emerging franchises by providing a cloud-based software platform, and marketing solutions to entrepreneurs. The group are provider of SaaS all-in-one small business management software in addition to providing print and digital marketing solutions to SMBs. Its solutions enable small and medium-sized business clients to attract and generate new business leads, manage their customer relationships efficiently with artificial intelligence (AI) tools and automation. The group has two business segments; Thryv SaaS deriving maximum revenue and Thryv Marketing Services.
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.